Innotubilin 80mg Injection

About

Innotubilin 80mg Injection is a specialized parenteral medication containing 80mg of its active cytotoxic agent, typically administered intravenously. This medication is designed to interfere with cellular processes essential for rapid cell division, making it a key component in the treatment of various cancers. The active ingredient targets specific structures within cancer cells, such as microtubules, which are vital for cell structure and division. By disrupting these processes, Innotubilin 80mg inhibits the proliferation of malignant cells and induces their apoptosis, thereby slowing tumor growth and progression. Its injectable form ensures direct and complete systemic delivery, achieving therapeutic concentrations necessary to effectively combat widespread or aggressive cancers. The 80mg dosage is carefully determined based on specific cancer types and patient characteristics, aiming for maximal anti-tumor efficacy while managing potential systemic toxicities.

Uses

• Treatment of various solid tumors.
• Management of certain hematological malignancies.
• Adjuvant therapy after surgical resection of tumors.
• Palliative care for advanced cancers.

Directions For Use

Administer intravenously under the supervision of an oncologist. Dosage, infusion rate, and cycle duration are determined by the specific cancer protocol and patient tolerance.

Benefits

• Effective in inhibiting cancer cell proliferation.
• Induces apoptosis in malignant cells.
• Can reduce tumor size and spread.
• Improves progression-free survival in some cancers.
• Part of established chemotherapy regimens.
• Offers a systemic approach to cancer treatment.

Side Effects

• Nausea and vomiting.
• Hair loss (alopecia).
• Fatigue and weakness.
• Myelosuppression (low blood counts).
• Peripheral neuropathy (numbness, tingling).
• Diarrhea or constipation.
• Mucositis (mouth sores).
• Injection site reactions.
• Allergic reactions.
• Muscle and joint pain.
• Liver function abnormalities.
• Kidney function impairment.

Safety Measures

• Alcohol - Avoid alcohol during treatment as it may exacerbate liver toxicity and gastrointestinal side effects.
• Pregnancy - Contraindicated during pregnancy due to severe teratogenic effects; effective contraception is mandatory for both male and female patients.
• Breastfeeding - Not recommended; discontinue breastfeeding due to potential harm to the infant from excretion in breast milk.
• Liver - Use with extreme caution in patients with hepatic impairment; significant dose adjustments are often required, and liver function must be closely monitored.
• Kidney - Exercise caution in patients with renal dysfunction; dose modification may be necessary, and kidney function should be regularly assessed.
• Lung - Use with caution in patients with pre-existing lung conditions, as some cytotoxic agents can cause pulmonary toxicity.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.